A double-blind, randomised, crossover trial of two botulinum toxin type a in patients with spasticity.

A double-blind, randomised, crossover trial of two botulinum toxin type a in patients with spasticity.

Botulinum toxin type A (btxA) is one of the main treatment choices for patients with spasticity. Prosigne® a new released botulinum toxin serotype A may have the same effectiveness as Botox® in focal dystonia. However, there are no randomized clinical trials comparing these formulations in spasticit...

Full description

Bibliographic Details
Main Authors: Fábio Coelho Guarany, Paulo Dornelles Picon, Nicole Ruas Guarany, Antonio Cardoso dos Santos, Bianca Paula Mentz Chiella, Carolina Rocha Barone, Lúcia Costa Cabral Fendt, Pedro Schestatsky
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3585303?pdf=render

Internet

http://europepmc.org/articles/PMC3585303?pdf=render

Similar Items